Anxiety does not predict response to antidepressant treatment in late life depression: results of a meta‐analysis
Authors:
- 30 March 2009
- journal article
- research article
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 24 (5) , 539-544
Abstract
Objective: Previous studies of mixed aged and older adult samples with major depressive disorder (MDD) reported reduced depression response in anxious patients, but a systematic review and analysis has not been performed. Our aim was to determine if anxiety predicts antidepressant response in previously identified placebo‐controlled trials of second generation antidepressants for late‐life depression.Method: From a previous systematic review that identified ten randomized, placebo‐controlled trials of community dwelling patients aged 60 or older with major depression, anxious patients were identified by a score ≥7 on the anxiety/somatization factor of the Hamilton Depression Rating Scale (HDRS). Response was defined as 50% or greater improvement on the HDRS or the Montgomery Asberg Depression Rating Scale. A meta‐analysis was performed using a random effects model to calculate Odds Ratios (OR).Results: Data were available from eight trials having ten drug‐placebo contrasts that included 2322 anxious and 1387 non‐anxious patients. The odds ratio for response to drug compared to placebo in anxious patients was 1.57 (95% CI 1.15, 2.14; z = 2.86, n = 10, p < 0.001), in non‐anxious patients was 1.44 (95% CI 1.15, 1.80, z = 3.21, n = 10, p < 0.001), and did not differ between groups. Pooled response rates to drug and placebo respectively were 49.4% vs 37.4% in anxious patients and 44.2 vs 35.5% in non‐anxious patients.Conclusions: In randomized, placebo‐controlled trials, anxiety in late‐life depression was not associated with decreased response to second generation antidepressants. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 24 references indexed in Scilit:
- Safety and Tolerability of Duloxetine at 60 mg Once Daily in Elderly Patients With Major Depressive DisorderJournal of Clinical Psychopharmacology, 2008
- Escitalopram in the Acute Treatment of Depressed Patients Aged 60 Years or OlderThe American Journal of Geriatric Psychiatry, 2008
- Predicting 6‐week treatment response to escitalopram pharmacotherapy in late‐life major depressive disorderInternational Journal of Geriatric Psychiatry, 2007
- Antidepressant Pharmacotherapy in the Treatment of Depression in the Very Old: A Randomized, Placebo-Controlled TrialAmerican Journal of Psychiatry, 2004
- Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*DPsychological Medicine, 2004
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- A Double-Blind, Placebo-Controlled Clinical Trial of Fluoxetine in Geriatric Patients With Major DepressionInternational Psychogeriatrics, 1995
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960